US Stock MarketDetailed Quotes

Cytosorbents (CTSO)

Watchlist
  • 0.7020
  • +0.0113+1.64%
Close Jan 16 16:00 ET
  • 0.7020
  • 0.00000.00%
Post 16:00 ET
44.09MMarket Cap-3.90P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cytosorbents (CTSO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
10.12%9.49M
8.76%9.62M
-2.92%8.73M
14.51%35.59M
24.52%9.15M
11.08%8.61M
9.53%8.84M
13.65%8.99M
5.88%31.08M
-3.84%7.35M
Operating revenue
10.12%9.49M
8.76%9.62M
-2.92%8.73M
14.51%35.59M
24.52%9.15M
11.08%8.61M
9.53%8.84M
13.65%8.99M
5.88%31.08M
-3.84%7.35M
Cost of revenue
-16.03%2.82M
19.84%2.8M
19.08%2.52M
14.64%10.47M
280.88%2.66M
4.78%3.36M
-31.25%2.34M
-47.03%2.12M
-34.57%9.13M
-140.42%-1.47M
Gross profit
26.83%6.67M
4.78%6.81M
-9.69%6.21M
14.45%25.13M
-26.35%6.49M
15.52%5.26M
39.25%6.5M
75.53%6.87M
42.52%21.95M
119.96%8.82M
Operating expense
-5.53%9.53M
3.53%10.43M
-12.45%10.09M
-22.24%41.91M
-45.90%10.22M
-15.25%10.09M
-10.30%10.07M
-2.35%11.53M
14.87%53.9M
82.33%18.9M
Selling and administrative expenses
4.24%8.61M
7.17%9.17M
-9.17%8.43M
-8.64%35M
-19.04%8.9M
-10.29%8.26M
-3.98%8.55M
1.65%9.28M
3.15%38.31M
26.17%10.99M
-General and administrative expense
----
----
----
----
----
-15.00%7.83M
-5.69%8.4M
1.26%9.25M
----
----
Research and development costs
-49.73%918K
-16.92%1.26M
-25.99%1.66M
-55.65%6.92M
-66.58%1.32M
-51.30%1.83M
-58.60%1.52M
-46.69%2.25M
3.15%15.59M
16.46%3.96M
Other operating expenses
----
----
----
----
----
26.42%-777.59K
21.92%-1.05M
48.24%-796.77K
----
----
Operating profit
40.75%-2.86M
-1.26%-3.62M
16.52%-3.89M
47.46%-16.79M
63.01%-3.73M
34.29%-4.83M
45.57%-3.57M
41.00%-4.66M
-1.35%-31.95M
-58.59%-10.08M
Net non-operating interest income expense
-9.69%-645K
-242.22%-616K
-8,995.66%-605.13K
-786.11%-1.4M
-1,094.91%-624.09K
-1,646.36%-588K
-1,940.58%-180K
89.47%-6.65K
-219.08%-157.89K
-197.17%-52.23K
Non-operating interest expense
9.69%645K
242.22%616K
8,995.66%605.13K
786.11%1.4M
1,094.91%624.09K
1,646.36%588K
--180K
--6.65K
--157.89K
--52.23K
Total other finance cost
----
----
----
----
----
----
1,941.70%180.1K
-89.47%6.65K
----
----
Other net income (expense)
-102.42%-64K
1,235.66%6.18M
311.41%3.01M
-306.49%-4.22M
-278.68%-4.9M
246.44%2.65M
-231.09%-544K
-326.70%-1.43M
181.32%2.05M
-38.23%2.75M
Gain on sale of security
-102.42%-64K
1,235.66%6.18M
311.41%3.01M
-316.73%-4.22M
-282.79%-4.9M
246.44%2.65M
-231.09%-544K
-315.79%-1.43M
179.61%1.95M
-40.61%2.68M
Other non- operating income (expenses)
----
----
----
-100.03%-30
----
----
----
----
243.76%96.76K
183.30%61.76K
Income before tax
-29.01%-3.57M
145.34%1.95M
75.72%-1.48M
25.45%-22.41M
-25.31%-9.26M
69.89%-2.77M
30.21%-4.29M
16.89%-6.09M
11.34%-30.06M
-297.48%-7.39M
Income tax
-401K
0
-107.78%-1.69M
-107.78%-1.69M
0
0
0
25.52%-813.74K
25.52%-813.74K
Net income
-14.52%-3.17M
145.34%1.95M
75.72%-1.48M
29.16%-20.72M
-15.10%-7.57M
69.89%-2.77M
30.21%-4.29M
16.89%-6.09M
10.87%-29.25M
-758.12%-6.57M
Net income continuous Operations
-14.52%-3.17M
145.34%1.95M
75.72%-1.48M
29.16%-20.72M
-15.10%-7.57M
69.89%-2.77M
30.21%-4.29M
16.89%-6.09M
10.87%-29.25M
-758.12%-6.57M
Minority interest income
Net income attributable to the parent company
-14.52%-3.17M
145.34%1.95M
75.72%-1.48M
29.16%-20.72M
-15.10%-7.57M
69.89%-2.77M
30.21%-4.29M
16.89%-6.09M
10.87%-29.25M
-758.12%-6.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-14.52%-3.17M
145.34%1.95M
75.72%-1.48M
29.16%-20.72M
-15.10%-7.57M
69.89%-2.77M
30.21%-4.29M
16.89%-6.09M
10.87%-29.25M
-758.12%-6.57M
Basic earnings per share
0.00%-0.05
137.50%0.03
81.82%-0.02
41.54%-0.38
-5.60%-0.14
76.07%-0.05
42.57%-0.08
34.97%-0.11
12.90%-0.65
-1,232.40%-0.1326
Diluted earnings per share
0.00%-0.05
137.50%0.03
81.82%-0.02
41.54%-0.38
-5.60%-0.14
76.07%-0.05
42.57%-0.08
34.97%-0.11
12.90%-0.65
-1,232.40%-0.1326
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 10.12%9.49M8.76%9.62M-2.92%8.73M14.51%35.59M24.52%9.15M11.08%8.61M9.53%8.84M13.65%8.99M5.88%31.08M-3.84%7.35M
Operating revenue 10.12%9.49M8.76%9.62M-2.92%8.73M14.51%35.59M24.52%9.15M11.08%8.61M9.53%8.84M13.65%8.99M5.88%31.08M-3.84%7.35M
Cost of revenue -16.03%2.82M19.84%2.8M19.08%2.52M14.64%10.47M280.88%2.66M4.78%3.36M-31.25%2.34M-47.03%2.12M-34.57%9.13M-140.42%-1.47M
Gross profit 26.83%6.67M4.78%6.81M-9.69%6.21M14.45%25.13M-26.35%6.49M15.52%5.26M39.25%6.5M75.53%6.87M42.52%21.95M119.96%8.82M
Operating expense -5.53%9.53M3.53%10.43M-12.45%10.09M-22.24%41.91M-45.90%10.22M-15.25%10.09M-10.30%10.07M-2.35%11.53M14.87%53.9M82.33%18.9M
Selling and administrative expenses 4.24%8.61M7.17%9.17M-9.17%8.43M-8.64%35M-19.04%8.9M-10.29%8.26M-3.98%8.55M1.65%9.28M3.15%38.31M26.17%10.99M
-General and administrative expense ---------------------15.00%7.83M-5.69%8.4M1.26%9.25M--------
Research and development costs -49.73%918K-16.92%1.26M-25.99%1.66M-55.65%6.92M-66.58%1.32M-51.30%1.83M-58.60%1.52M-46.69%2.25M3.15%15.59M16.46%3.96M
Other operating expenses --------------------26.42%-777.59K21.92%-1.05M48.24%-796.77K--------
Operating profit 40.75%-2.86M-1.26%-3.62M16.52%-3.89M47.46%-16.79M63.01%-3.73M34.29%-4.83M45.57%-3.57M41.00%-4.66M-1.35%-31.95M-58.59%-10.08M
Net non-operating interest income expense -9.69%-645K-242.22%-616K-8,995.66%-605.13K-786.11%-1.4M-1,094.91%-624.09K-1,646.36%-588K-1,940.58%-180K89.47%-6.65K-219.08%-157.89K-197.17%-52.23K
Non-operating interest expense 9.69%645K242.22%616K8,995.66%605.13K786.11%1.4M1,094.91%624.09K1,646.36%588K--180K--6.65K--157.89K--52.23K
Total other finance cost ------------------------1,941.70%180.1K-89.47%6.65K--------
Other net income (expense) -102.42%-64K1,235.66%6.18M311.41%3.01M-306.49%-4.22M-278.68%-4.9M246.44%2.65M-231.09%-544K-326.70%-1.43M181.32%2.05M-38.23%2.75M
Gain on sale of security -102.42%-64K1,235.66%6.18M311.41%3.01M-316.73%-4.22M-282.79%-4.9M246.44%2.65M-231.09%-544K-315.79%-1.43M179.61%1.95M-40.61%2.68M
Other non- operating income (expenses) -------------100.03%-30----------------243.76%96.76K183.30%61.76K
Income before tax -29.01%-3.57M145.34%1.95M75.72%-1.48M25.45%-22.41M-25.31%-9.26M69.89%-2.77M30.21%-4.29M16.89%-6.09M11.34%-30.06M-297.48%-7.39M
Income tax -401K0-107.78%-1.69M-107.78%-1.69M00025.52%-813.74K25.52%-813.74K
Net income -14.52%-3.17M145.34%1.95M75.72%-1.48M29.16%-20.72M-15.10%-7.57M69.89%-2.77M30.21%-4.29M16.89%-6.09M10.87%-29.25M-758.12%-6.57M
Net income continuous Operations -14.52%-3.17M145.34%1.95M75.72%-1.48M29.16%-20.72M-15.10%-7.57M69.89%-2.77M30.21%-4.29M16.89%-6.09M10.87%-29.25M-758.12%-6.57M
Minority interest income
Net income attributable to the parent company -14.52%-3.17M145.34%1.95M75.72%-1.48M29.16%-20.72M-15.10%-7.57M69.89%-2.77M30.21%-4.29M16.89%-6.09M10.87%-29.25M-758.12%-6.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -14.52%-3.17M145.34%1.95M75.72%-1.48M29.16%-20.72M-15.10%-7.57M69.89%-2.77M30.21%-4.29M16.89%-6.09M10.87%-29.25M-758.12%-6.57M
Basic earnings per share 0.00%-0.05137.50%0.0381.82%-0.0241.54%-0.38-5.60%-0.1476.07%-0.0542.57%-0.0834.97%-0.1112.90%-0.65-1,232.40%-0.1326
Diluted earnings per share 0.00%-0.05137.50%0.0381.82%-0.0241.54%-0.38-5.60%-0.1476.07%-0.0542.57%-0.0834.97%-0.1112.90%-0.65-1,232.40%-0.1326
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -